EGFR and pancreatic neoplasm: Pancreatic cancer treated with CT, a selective STAT3 inhibitor, and Gefitinib (EGFR inhibitor) also showed encouraging results with the lowest time capable of inducing cell death in all eight pancreatic cancer cells examined.